ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Cardiovascular Systems, Inc. CSII recently announced an acquisition option agreement with Chansu Vascular Technologies, LLC (CVT) for the development of a peripheral everolimus drug-coated balloon ...
With the help of a small California startup, Cardiovascular Systems has laid out plans to build a full portfolio of minimally invasive medical hardware designed to remove blood clots. The devicemaker ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
The Molecular Physiology of the Cardiovascular System training program is a multi-disciplinary training program for pre- and postdoctoral trainees. The goal of our program is to train students and ...
Illinois-based medical technology giant Abbott will acquire New Brighton-based medical device company Cardiovascular Systems Inc., the companies announced Wednesday. Under the terms of the agreement, ...
“We are pleased with the state of our business and our performance in the first quarter. Q1 revenue of $59.7 million represented 2.2% revenue growth compared to last year. Worldwide coronary revenue ...
A tool like a tiny orbital sander is the heart of the Diamondback 360° system, a medical device that removes plaque from the walls of arteries in the leg. It’s the flagship product of Cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results